185 related articles for article (PubMed ID: 35211430)
1. The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience.
Kostik MM; Raupov RK; Suspitsin EN; Isupova EA; Gaidar EV; Gabrusskaya TV; Kaneva MA; Snegireva LS; Likhacheva TS; Miulkidzhan RS; Kosmin AV; Tumakova AV; Masalova VV; Dubko MF; Kalashnikova OV; Aksentijevich I; Chasnyk VG
Front Pediatr; 2022; 10():820586. PubMed ID: 35211430
[TBL] [Abstract][Full Text] [Related]
2. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study.
Solignac M; Cabrera N; Fouillet-Desjonqueres M; Duquesne A; Laurent A; Foray AP; Viel S; Zekre F; Belot A
J Autoimmun; 2024 May; 147():103248. PubMed ID: 38797048
[TBL] [Abstract][Full Text] [Related]
3. JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis.
Miserocchi E; Giuffrè C; Cornalba M; Pontikaki I; Cimaz R
Clin Rheumatol; 2020 Mar; 39(3):847-851. PubMed ID: 31897953
[TBL] [Abstract][Full Text] [Related]
4. JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology.
Ll Wilkinson MG; Deakin CT; Papadopoulou C; Eleftheriou D; Wedderburn LR
Pediatr Rheumatol Online J; 2021 Sep; 19(1):146. PubMed ID: 34563217
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the clinical characteristics and therapeutic effect of refractory juvenile dermatomyositis to tofacitinib].
Zhou QF; Luo Y; He TY; Ling JY; Xu YB; Yang J; Xia Y
Zhonghua Er Ke Za Zhi; 2023 Jun; 61(6):538-542. PubMed ID: 37312466
[No Abstract] [Full Text] [Related]
6. Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials.
Welzel T; Winskill C; Zhang N; Woerner A; Pfister M
Pediatr Rheumatol Online J; 2021 Mar; 19(1):46. PubMed ID: 33766063
[TBL] [Abstract][Full Text] [Related]
7. JAK Inhibition in Juvenile Idiopathic Arthritis (JIA): Better Understanding of a Promising Therapy for Refractory Cases.
Melki I; Frémond ML
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510809
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study.
Ruperto N; Brunner HI; Zuber Z; Tzaribachev N; Kingsbury DJ; Foeldvari I; Horneff G; Smolewska E; Vehe RK; Hazra A; Wang R; Mebus CA; Alvey C; Lamba M; Krishnaswami S; Stock TC; Wang M; Suehiro R; Martini A; Lovell DJ; ;
Pediatr Rheumatol Online J; 2017 Dec; 15(1):86. PubMed ID: 29282090
[TBL] [Abstract][Full Text] [Related]
9. Successful management with Janus kinase inhibitor tofacitinib in refractory juvenile dermatomyositis: a pilot study and literature review.
Yu Z; Wang L; Quan M; Zhang T; Song H
Rheumatology (Oxford); 2021 Apr; 60(4):1700-1707. PubMed ID: 33024992
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of paediatric rheumatic diseases in Nigeria.
Olaosebikan BH; Adelowo OO; Animashaun BA; Akintayo RO
Pediatr Rheumatol Online J; 2017 Jan; 15(1):7. PubMed ID: 28143550
[TBL] [Abstract][Full Text] [Related]
11. Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders.
Poddighe D; Romano M; Dossybayeva K; Abdukhakimova D; Galiyeva D; Demirkaya E
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207358
[TBL] [Abstract][Full Text] [Related]
12. Effect of the JAK/STAT Inhibitor Tofacitinib on Macrophage Cholesterol Metabolism.
Adorni MP; Papotti B; Borghi MO; Raschi E; Zimetti F; Bernini F; Meroni PL; Ronda N
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628747
[TBL] [Abstract][Full Text] [Related]
13. Familial autoimmunity in the Childhood Arthritis and Rheumatology Research Alliance registry.
Prahalad S; McCracken CE; Ponder LA; Angeles-Han ST; Rouster Stevens KA; Vogler LB; Langefeld CD; Thompson SD;
Pediatr Rheumatol Online J; 2016 Mar; 14(1):14. PubMed ID: 26965173
[TBL] [Abstract][Full Text] [Related]
14. Update on biologic therapies for juvenile idiopathic arthritis-associated uveitis.
Thomas J; Kuthyar S; Shantha JG; Angeles-Han ST; Yeh S
Ann Eye Sci; 2021 Jun; 6():. PubMed ID: 34131629
[TBL] [Abstract][Full Text] [Related]
15. Scope of JAK Inhibitors in Children: Recent Evidence and Way Forward.
Bagri NK; Chew C; Ramanan AV
Paediatr Drugs; 2023 Nov; 25(6):635-647. PubMed ID: 37775678
[TBL] [Abstract][Full Text] [Related]
16. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
[TBL] [Abstract][Full Text] [Related]
17. Safety and Effectiveness of Tofacitinib in Treating Polyarticular Course Juvenile Idiopathic Arthritis.
Jones NT; Keller CL; Abadie RB; Bratton MB; Henderson EJ; Moore P; Rieger R; Ahmadzadeh S; Tirumala S; Varrassi G; Shekoohi S; Kaye AD
Cureus; 2023 Nov; 15(11):e48258. PubMed ID: 38054155
[TBL] [Abstract][Full Text] [Related]
18. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
Kim H; Gunter-Rahman F; McGrath JA; Lee E; de Jesus AA; Targoff IN; Huang Y; O'Hanlon TP; Tsai WL; Gadina M; Miller FW; Goldbach-Mansky R; Rider LG
Arthritis Res Ther; 2020 Apr; 22(1):69. PubMed ID: 32252809
[TBL] [Abstract][Full Text] [Related]
19. The off-label uses profile of tofacitinib in systemic rheumatic diseases.
Zhao Z; Ye C; Dong L
Int Immunopharmacol; 2020 Jun; 83():106480. PubMed ID: 32283509
[TBL] [Abstract][Full Text] [Related]
20. A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
Lovell DJ; Dare JA; Francis-Sedlak M; Ball J; LaMoreaux BD; Von Scheven E; Reinhardt A; Jerath R; Alpan O; Gupta R; Goldsmith D; Zeft A; Naddaf H; Gottlieb B; Jung L; Holt RJ
Pediatr Rheumatol Online J; 2018 Jun; 16(1):41. PubMed ID: 29941047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
